tbuckley/cabot-search huggingface dataset:
EP02.01-002 Development of Circulating and Tissue Biomarkers Predicting Immune Phenotype and Response to Immunotherapy in NSCLC.
Authors: B.D. Henderson, P. Maguire, S.I. Keartland, M.P. Barr, B.P. Crulhas, G. Keating, G.J. Fitzmaurice, S. Gray, S. Nicholson, S.P. Finn, K.A. Gately
Journal: Journal of Thoracic Oncology (2022)
MA12.07 Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma with Lepidic Growth
Authors: e. thunnissen, A. Borczuk, M.B. Beasly, M. Tsao, K. Kerr, S. Dacic, Y. Minami, A. Nicholson, B. Lissenberg-Witte, A. Roden, M. Papotti, C. Poleri, B. Travis, D. Jain, G. Pelosi, J.H. Chung, J. Botling, L. Bubendorf, M. Mino-Kenudson, N. Motoi, S. Lantuejoul, W. Cooper, D. Hwang, A. Moreira, M. Noguchi
Journal: Journal of Thoracic Oncology (2022)
EP01.01-012 Clinical and Molecular Features of Chinese Early-stage Multiple Primary Lung Cancer Patients
Authors: Y. Wang, P. Li, R. Yang, D. Wang, L. Wang, S. Wang, C. Liu, J. Li, C. Liu, Y. Tong, Y. Zhang, F. Meng, P. Du, L. Li
Journal: Journal of Thoracic Oncology (2022)
EP02.04-003 A Retrospective Comparison of Survival Outcomes in EGFR-mutated, NSCLC Patients on Osimertinib +/- Brain Metastases
Authors: I. Litt, A. Gibson, M. Dean, A. Elegbede, G. Bebb, W. Cheung, A. Pabani
Journal: Journal of Thoracic Oncology (2022)
MA11.05 The Blood Proteome of Imminent Lung Cancer
Authors: H. Zahed, K. Smith-Byrne, K. Alcala, F. Guida, M. Johansson, V. Stevens, A. Langhammer, R.L. Milne, J.-M. Yuan, H.A. Robbins, M. Johansson
Journal: Journal of Thoracic Oncology (2022)
EP08.01-044 A Phase 2 Multi-Cohort Study of Tiragolumab, Atezolizumab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer
Authors: J. Reuss, D. Wonser, K.N. Smith, J. Ahn, S. Byers, K. Creswell, C. Kim, K. Parikh, J.E. Thompson, J. Crawford, E. Cohen, J. Zeck, M. Gutierrez, S.V. Liu
Journal: Journal of Thoracic Oncology (2022)
EP01.01-008 Expression of PD-L1 mRNA and Its Epigenetic Regulators: MicroRNA-17, -93 and -142 in Early Stages NSCLC Patients’ Plasma
Authors: N. Krzyzanowska, A. Grenda, K. Wojas-Krawczyk, I. Chmielewska, T. Jankowski, G. Jankowski, A. Kamińska, P. Krawczyk, J. Milanowski
Journal: Journal of Thoracic Oncology (2022)
EP05.02-009 Aumolertinib Versus Erlotinib/Chemotherapy for Neoadjuvant Treatment of Stage IIIA EGFR-mutant NSCLC (ANSWER)
Authors: W. Liang, E. Xu, J. Zhao, M. Wang, Z. Zhang, Y. Liang, C. Cheng, G. Wang, C. Zhong, Z. Liang, X. Chen, B. Zheng, Y. Huang, J. Hu, L. Xu, M. Xie, N. Liang, S. Xu, J. Liu, L. Wei, Z. Peng, G. Zhang, S. Zhang, S. Xu, J. He
Journal: Journal of Thoracic Oncology (2022)
EP08.01-075 Combination of Baseline Disease and Smoking Pack-Years Can Guide The 1st-line Treatment Decision in Advanced NSCLC with High PD-L1 Expression
Authors: R. Yuan, A. Silver, M. Ye, C. Ho, J. Zhang, Y. Wang, L. Wu, M. Martin, S. Lam, C. MacAulay, B. Melosky
Journal: Journal of Thoracic Oncology (2022)
EP05.01-015 Validate Radiomics Features and XGBoost Model in Radiation Pneumonitis (RP) Prediction in Patients with Primary Lung Cancer: A MultiCenter Study
Authors: J. Liu, H. Sun, Y. Meng, X. Ye, S. Li, Y. Han, J. Ge, H. Yang, J. Liang, F.S. Kong
Journal: Journal of Thoracic Oncology (2022)
EP07.03-005 MesoGraph: Graph Neural Networks for Weakly Supervised Cellular Profiling in the Subtyping of Malignant Mesothelioma Images
Authors: M. Eastwood, S. Tudor Marc, X. Gao, H. Sailem, J. Offman, A. Montero Fernandez, D. Jonigk, W. Cookson, M. Moffat, S. Popat, J.L. Robertus, F. Minhas
Journal: Journal of Thoracic Oncology (2022)
MA13.04 Entrectinib in Patients with ROS1 Fusion-Positive (ROS1-fp) NSCLC: Updated Efficacy and Safety Analysis
Authors: Y. Fan, A. Drilon, C.-H. Chiu, D.W. Bowles, H.H.F. Loong, S. Siena, K. Goto, M. Krzakowski, M.-J. Ahn, H. Murakami, R. Dziadziuszko, H. Zeuner, B. Pitcher, D. Cheick, M.G. Krebs
Journal: Journal of Thoracic Oncology (2022)
EP05.02-007 Impact Of Fibrinogen Levels and mGPS on Survival of Stage III/N2 NSCLC Patients Treated with Neoadjuvant Therapy and Radical Surgery
Authors: K. Sinn, B. Mosleh, M. Grusch, K. Hoetzenecker, T. Klikovits, D. Gompelmann, M.A. Hoda
Journal: Journal of Thoracic Oncology (2022)
EP04.01-022 Real-world Evidence of Durvalumab for Stage III NSCLC: Survival Outcomes and Patterns of Care Post-progression
Authors: P. Aguiar, P. Martins de Marchi, T. Caldas Montella, I. Favato Barcelos, G. Monte Tenório Taveira, R. Duarte Paes, R. Dienstmann, C.G. Moreira Ferreira
Journal: Journal of Thoracic Oncology (2022)
EP05.01-024 Real-life Management of Stage III NSCLC Patients in Italy: The BE-PACIFIC Observational Study
Authors: S. Novello, A. Morabito, S. Silipigni, V. Adamo, P. Bironzo, S. Rossi, M. Tiseo, M. Montrone, I. Facilissimo, G. Romano, I. Stasi, G. Ceresoli, C. Gridelli, A. Lugini, S. Pilotto, P. Tagliaferri, E. Bria, D. Cortinovis, F. Grossi, P. Borghetti, M. Brighenti, A.M. Carta, L. Ciuffreda, R. Giusti, M. Macerelli, F. Verderame, F. Zanelli, R. Berardi, V. Gregorc, C. Sergi, E. Vattemi, R. Ferrara, P.L. Piovano, V. Scotti, G. Borra, S. Gori, M. Aieta, A. Bertolini, F. Cecere, G. Pasello, D. Rocco, G. Lo Certo, L. Simoni, S. Ramella
Journal: Journal of Thoracic Oncology (2022)
EP01.03-006 Potential Drivers of Lung Cancer Screening Participation in Australia: A Qualitative Study to Inform Future Implementation
Authors: K.L.a. Dunlop, H.M. Marshall, E. Stone, A.R. Sharman, R. Dodd, J. Rhee, S. McCullough, N.M. Rankin
Journal: Journal of Thoracic Oncology (2022)
Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements
Authors: Jonah Larkins-Ford, Yonatan N. Degefu, Nhi Van, Artem Sokolov, Bree B. Aldridge
Journal: Cell Reports Medicine (2022)

A challenge in tuberculosis treatment regimen design is the necessity to combine three or more antibiotics. We narrow the prohibitively large search space by breaking down high-order drug combinations into drug pair units. Using pairwise in vitro measurements, we train machine learning models to predict higher-order combination treatment outcomes in the relapsing BALB/c mouse model. Classifiers perform well and predict many of the >500 possible combinations among 12 antibiotics to be improved over bedaquiline + pretomanid + linezolid, a treatment-shortening regimen compared with the standard of care in mice. We reformulate classifiers as simple rulesets to reveal guiding principles of constructing combination therapies for both preclinical and clinical outcomes. One example ruleset combines a drug pair that is synergistic in a dormancy model with a pair that is potent in a cholesterol-rich growth environment. These rulesets are predictive, intuitive, and practical, thus enabling rational construction of drug combinations.
EP14.03-001 DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive Stage Small Cell Lung Cancer
Authors: A. Juloori, G. Gan, J. Zhang, M.E. Abazeed, J. Hara, A.M. Baschnagel, A. Traynor, M. Bassetti, J. Patel, S. Chmura, C. Bestvina
Journal: Journal of Thoracic Oncology (2022)
OA06.07 Stereotactic Ablative Radiotherapy Before Resection to AvoId Delay for Early-Stage LunG Cancer or OligomEts
Authors: B. Kidane, J. Spicer, J.O. Kim, I.J. Gerard, B. Abdulkarim, P.-O. Fiset, M.J. Cecchini, R.A. Malthaner, R.I. Inculet, E. Wakeam, D. Fortin, P. Wawryko, G. Qing, D.A. Palma
Journal: Journal of Thoracic Oncology (2022)
MA04.08 Navigation Bronchoscopy Mediated Sentinel Lymph Node Procedure: an Explorative Study in Ex-vivo Lung Cancer Specimens
Authors: D.K.M. ter Woerds, R.L.J. Verhoeven, S.M. van der Heide, A.F.T.M. Verhagen, E.H.J.G. Aarntzen, E.H.F.M. van der Heijden
Journal: Journal of Thoracic Oncology (2022)
OA02.05 Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study
Authors: Y.-L. Wu, Q. Zhou, M. Chen, Y. Pan, O. Jian, D. Hu, Q. Lin, G. Wu, J. Cui, J. Chang, Y. Cheng, C. Huang, A. Liu, N. Yang, Y. Gong, C. Zhu, Z. Ma, J. Fang, G. Chen, J. Zhao, A. Shi, Y. Lin, G. Li, Y. Liu, D. Wang, R. Wu, X. Xu, J. Shi, Z. Liu, J. Wang, J. Yang
Journal: Journal of Thoracic Oncology (2022)
MA01.03 Exploiting DNA Methylation for Classification of SCLC Subtypes from Liquid Biopsies Using a Robust Machine Learning Approach
Authors: S. Heeke, C.M. Gay, M.R. Estecio, A. Stewart, H. Tran, B. Zhang, X. Tang, M.G. Raso, K. Concannon, L. Guimaraes De Sousa, W.E. Lewis, K. Kondo, M.B. Nilsson, Y. Xi, L. Diao, Q. Wang, J. Zhang, J. Wang, I.I. Wistuba, L.A. Byers, J.V. Heymach
Journal: Journal of Thoracic Oncology (2022)
MA12.04 SAKK 16/14: CD8 T Cell Positioning Correlates with Survivalin Stage IIIA(N2) NSCLC After Neoadjuvant Immunotherapy
Authors: B. Sobottka, G. Tochtermann, M. Trueb, M. Nowack, I. Alborelli, K. Leonards, M. Manzo, E. Keller, P. Herzig, D. Schmid, E.I. Eboulet, S. Hayoz, G. Godar, M. Schneider, P. Jermann, S. Savic Prince, D. König, M. Pless, A. Zippelius, S.I. Rothschild, V.H. Koelzer
Journal: Journal of Thoracic Oncology (2022)
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China
Authors: Song Gu, Jidong Lai, Wenqing Kang, Yangfang Li, Xueping Zhu, Tongzhen Ji, Jinxing Feng, Liping Zhao, Zhankui Li, Lijie Dong, Guoqiang Hou, Yao Zhu, Zhaohui Li, Canlin He, Haifeng Geng, Dan Pang, Yajuan Wang
Journal: Journal of Infection (2022)
P1.15-11 Durvalumab + Olaparib vs Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: Outcomes from the Phase 2 ORION Study
Authors: M-j. Ahn, D. Spigel, I. Bondarenko, E. Kalinka, B.C. Cho, S. Sugawara, G. Galffy, B.Y. Shim, N. Kislov, R. Nagarkar, I. Demedts, S.J.M. Gans, D.M. Oliva, R. Stewart, Z. Lai, E. Grainger, X. Shi, M. Hussein
Journal: Journal of Thoracic Oncology (2022)
EP02.02-003 Mean Lung Dose Correlates with Volume of Radiation-Induced Lung Injury in Patients Treated with SABR for Lung Cancer
Authors: A.J. Killean, R. Ramaesh, R. Turnbull, W.H. Nailon, D.B. McLaren, I.D. Phillips
Journal: Journal of Thoracic Oncology (2022)
P1.15-05 Nintedanib in Combination with Nivolumab in Pretreated Patients with Advanced Adenocarcinoma of the Lung (AIO-TRK-0117 Phase IB/II Trial)
Authors: M. Reck, P. Sadjadian, C. Waller, K. Kambartel, C. Grohe, A. Rittmeyer, A. Sendler, N. Reinmuth, R. Keller, H. von Suchodoletz, M. Maenz, M. Sebastian
Journal: Journal of Thoracic Oncology (2022)
MA13.09 Time from Immune Checkpoint Inhibitor to Sotorasib Use Correlates with Risk of Hepatotoxicity in Non-small Cell Lung Cancer
Authors: S. Rakshit, R. Bansal, A. Potter, R. Manochakian, Y. Lou, Y. Zhao, V. Ernani, P. Savvides, A. Schwecke, N. Moffett, C. Hocum, K. Leventakos, A. Adjei, R. Marks, J. Molina, A. Mansfield, A. Dimou
Journal: Journal of Thoracic Oncology (2022)
EP02.03-002 Impact of Society and National Guidelines on Patient Selection for Lung Cancer Surgery in the UK from 2008 to 2013
Authors: A. Pons, P. De Sousa, C. Proli, S.A. Booth, A. Palmares, M. Leung, A. Alshammari, D. Vlastos, H. Raubenheimer, M. Devbhandari, A. Patel, E. Lim
Journal: Journal of Thoracic Oncology (2022)
OA15.05 HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy
Authors: B. Besse, M.M. Awad, P.M. Forde, M. Thomas, G. Goss, B. Aronson, R. Hobson, E. Dean, J. Peters, S. Iyer, J. Conway, J.C. Barrett, J. Cosaert, M. Dressman, S.T. Barry, J.V. Heymach
Journal: Journal of Thoracic Oncology (2022)
EP01.04-004 Overcoming the Barriers to Lung Cancer Screening using a Systemwide Approach
Authors: M.R. Gieske, R.F. Calhoun, G.M. Schmitt, I.A. Budhani, D. Alkapalan, A. Bramer, J.L. Kerns, R. Yadav, K. Ferguson, G.H. Kloecker
Journal: Journal of Thoracic Oncology (2022)
MA06.04 Phase II Study of Durvalumab Plus Concurrent Radiotherapy in Unresectable Locally Advanced NSCLC: DOLPHIN Study (WJOG11619L)
Authors: M. Tachihara, K. Tsujino, M. Shimokawa, T. Ishihara, H. Hayashi, Y. Sato, T. Kurata, S. Sugawara, Y. Shiraishi, S. Teraoka, K. Azuma, H. Daga, M. Yamaguchi, T. Kodaira, M. satouchi, N. Yamamoto, K. Nakagawa
Journal: Journal of Thoracic Oncology (2022)
P2.02-03 A Phase II Study of Metformin with Pemetrexed/Carboplatin in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer
Authors: S. Verma, P.S. Malik, K. Kalra, V. Singh, S. Kumar, S. Khurana, D. Pushpam, D. Jain, Y. Gupta
Journal: Journal of Thoracic Oncology (2022)
P1.05-02 Mutations in CREBBP are Associated with Local Failure after Lung Stereotactic Body Radiation Therapy
Authors: V. Ng, A. Rimner, B. Sidiqi, E.S. Lebow, N. Shaverdian, D.Y. Gelblum, A.F. Shepherd, C.B. Simone, D.R. Gomez, A.J. Wu
Journal: Journal of Thoracic Oncology (2022)
EP05.03-001 Impact of Neoadjuvant Chemo/radiotherapy Followed by Surgical Resection on T4N0-1 Non-Small Cell Lung Cancer
Authors: A. Turna, G. Özçıbık, H.I. Bulut, I. Sarbay, E. Ersen, H.V. Kara, K. Kaynak
Journal: Journal of Thoracic Oncology (2022)
P2.03-01 Initial Biodistribution Data of ImmunoPET A Phase 0/1 Study Characterising PD-L1 with 89 Zr-Durvalumab (MEDI4736) PET/CT
Authors: F. Hegi-Johnson, S. Rudd, J. Callahan, C. Wichmann, T. Akhurst, P. Roselt, T. John, P. Donnelly, A. Scott, G. Hanna, M. MacManus
Journal: Journal of Thoracic Oncology (2022)
EP05.01-014 Circulating Tumor DNA to Identify Genomic Biomarkers of Radiation Sensitivity in Locally Advanced Non-Small Cell Lung Cancer
Authors: E. Lebow, B.T. Li, N. Sheverdian, J. Eichholz, L.B. Kratochvil, D.Y. Gelblum, C.B. Simone, A.F. Shepherd, J.Y. Shin, A. Rimner, M.F. Berger, J.M. Isbell, D.R. Gomez
Journal: Journal of Thoracic Oncology (2022)
EP08.01-013 Ramucirumab plus Atezolizumab in Patients with Stage IV NSCLC Previously Treated with Immune Checkpoint Blockade
Authors: B. Herzog, S.N. Waqar, S. Devarakonda, J.P. Ward, R. Govindan, D. Morgensztern
Journal: Journal of Thoracic Oncology (2022)
EP02.03-029 Prognostic Factors in Curative Intent Stage I lung Adenocarcinoma: Hospital's Cancer Registry Based Analysis
Authors: V.G. Silva, F.C. Abrão, S.V. Peres, G.d.A. Rosamilia, R.d.M. Hanriot, R.N. Younes, I.R.L.B. de Abreu
Journal: Journal of Thoracic Oncology (2022)
MA07.05 Phase 1b/2 Study of Combined HER Inhibition in Refractory EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
Authors: J. Goldman, H.K.T. Huang, A. Cummings, Z. Noor, S. Slomowitz, E. Kirimis, O. Olevsky, K. Arzoo, S. Ashouri, B. DiCarlo, E.H.-L. Hu, D.J. Wong, J. Chauv, E.B. Garon, Y. Yarden, D. Slamon
Journal: Journal of Thoracic Oncology (2022)
OA06.05 Impact of COVID-19 Pandemic on Proportion and Treatment Patterns for Stage I Non-small Cell Lung Cancer in the Netherlands
Authors: N. Wolfhagen, H.J. Smit, O.C. Schuurbiers, J.S.A. Belderbos, A.F.T.M. Verhagen, H.W.H. Schreurs, R.A. Damhuis, D.J. Heineman
Journal: Journal of Thoracic Oncology (2022)
EP08.01-070 Safety and Efficacy of Sitravatinib + Tislelizumab in Patients with PD-L1+, Locally Advanced/Metastatic, Squamous NSCLC
Authors: J. Zhao, J. Cui, D. Huang, M. Sun, Z. Ma, Q. Chu, Y. Liu, Z. Wang, X. Li, H. Li, J. Zhang, J. Sun, C. Fei, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2022)
EP05.01-025 Planned Interim Analysis of a Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer
Authors: A. Rimner, K. Fitzgerald, A.N. Iqbal, A.F. Shepherd, D.R. Gomez, J.Y. Shin, D.Y. Gelblum, C. Hajj, F. Albrecht, R.R. Kotecha, I.R. Preeshagul, F.C. Santini, N. Shaverdian, A.J. Wu, C.B. Simone, M.S. Ginsberg, Z. Zhang, M.D. Offin, M.G. Kris, J.E. Chaft
Journal: Journal of Thoracic Oncology (2022)
MA01.04 Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance
Authors: Z. Megyesfalvi, N. Barany, A. Lantos, Z. Valko, O. Pipek, C. Lang, A. Schwendenwein, F. Oberndorfer, S. Paku, B. Ferencz, K. Dezso, J. Fillinger, Z. Lohinai, J. Moldvay, G. Galffy, M. Rezeli, C. Rivard, F. Hirsch, L. Brcic, H. Popper, I. Kern, M. Kovacevic, J. Skarda, M. Mittak, G. Marko-Varga, K. Bogos, F. Renyi-Vamos, M.A. Hoda, T. Klikovits, K. Hoetzenecker, K. Schelch, V. Laszlo, B. Dome
Journal: Journal of Thoracic Oncology (2022)
EP16.01-018 SAKK 16/14 -Peripheral Immune Cell Populations Inresponse to Neoadjuvant Durvalumab in Patients with Stage IIIA(N2) NSCLC
Authors: D. Schmid, M. Trueb, P. Herzig, C. Gärtner-Pelham, I. Alborelli, K. Leonards, M. Manzo, P. Jermann, S. Savic Prince, E. Keller, E.I. Eboulet, S. Hayoz, G. Godar, M. Schneider, D. König, M. Pless, A. Zippelius, S.I. Rothschild
Journal: Journal of Thoracic Oncology (2022)
EP04.01-019 Into the Wild: Assessing Acute Care for Lung Cancer Patients, A Cohort Study to Improve Cancer Care at Emergency Department
Authors: J.C. Sánchez González, B. Núñez García, M. Blanco Clemente, V. Calvo de Juan, M. Mendez Garcia, B. Cantos Sanchez de Ibargüen, M. Sanchez del Corral, A.J. Ramos-Vegue, A. Royuela, M. Provencio
Journal: Journal of Thoracic Oncology (2022)
MA04.04 The Ground-Glass Component Status Combined with the Clinical T Descriptor Predicts Prognosis and Genomic Alterations in NSCLC
Authors: Y. Yoshida, Y. Muraoka, M. Yotsukura, Y. Shinno, K. Nakagawa, H. Watanabe, K. Shiraishi, T. Kohno, R. Hamamoto, Y. Yatabe, S-i. Watanabe
Journal: Journal of Thoracic Oncology (2022)
MA12.09 Frequency and Detectability of Uncommon EGFR Mutations in NSCLC
Authors: H.M. O'Sullivan, S. MacMahon, W. Cui, C. Milner-Watts, N. Tokaca, J. Bhosle, M. Davidson, A. Minchom, N. Yousaf, M. O'Brien, S. Popat
Journal: Journal of Thoracic Oncology (2022)
EP01.01-009 Common MicroRNAs in Pre-diagnostic Serum Associated with Lung Cancer in Two Cohorts up to Eight Years Before Diagnosis: A HUNT Study
Authors: O.D. Røe, I. Fotopoulos, O.T.D. Nguyen, T.H. Nøst, M. Markaki, V. Lagani, R. Mjelle, T.M. Sandanger, P. Sætrom, I. Tsamardinos
Journal: Journal of Thoracic Oncology (2022)
MA10.04 Long-term Follow-up Study of Thymic Epithelial Tumors. Report of the Updated Nation-wide Database in Japan
Authors: M. Okumura, I. Yoshino, Y. Shintani, R. Nakanishi, T. Yoshikawa, H. Date, S-i. Toyooka, K. Shimizu, J. Nakajima, M. Tsuboi, S-i. Watanabe, H. Asamura
Journal: Journal of Thoracic Oncology (2022)
P2.01-02 Delivery of Concurrent Extracranial Stereotactic Body Radiotherapy with Osimertinib for Oligoprogressive EGFR Mutated Stage IV NSCLC
Authors: E. Tsur, T. Michaeli, H. Nechushtan, Y. Rotenberg, P. Blumenfeld
Journal: Journal of Thoracic Oncology (2022)
EP04.01-017 Cost-Effectiveness of Atezolizumab for Adjuvant Treatment of Patients with Stage II-IIIA PD-L1+ Non-small Cell Lung Cancer
Authors: M. Das, S. Ogale, A. Johnson, C. Nguyen, J. Bhagwakar, N. Jovanoski, J. Lee
Journal: Journal of Thoracic Oncology (2022)
EP05.01-012 Avoiding Cardiac Toxicity in Lung Cancer Radiotherapy (ACcoLade) Trial - Initial Results
Authors: K. Banfill, M. Schmitt, J. Riley, A. McWilliam, L. Pemberton, C. Chan, M. Harris, H. Sheikh, J. Coote, D. Woolf, N. Bayman, A. Salem, M. van Herk, C. Faivre-Finn
Journal: Journal of Thoracic Oncology (2022)
EP08.03-002 Local Ablative Therapy in Oligoprogressive NSCLC - Results from a Tertiary Cancer Center of India
Authors: A. Tibdewal, T. Tahmeed, J.P. Agarwal, K. Prabhash, N. Mummudi, V. Noronha, V. Patil, N. Menon, S. Chopade, A. Singh
Journal: Journal of Thoracic Oncology (2022)
EP05.03-004 Risk Prediction of Multiple-station N2 Metastasis in Patients with Clinical Single-station N2 Non-small Cell Lung Cancer
Authors: J.Y. Kim, J.K. Yun, G.D. Lee, S. Choi, H.R. Kim, Y.-H. Kim, D.K. Kim, S.-I. Park
Journal: Journal of Thoracic Oncology (2022)
EP01.07-005 Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Diagnosing Indeterminate Pulmonary Nodules
Authors: F. Wu, J. Liu, C. Hu, J. Liu, W. Zhao, Y. Wu, Y. Xu, J. Hu, L. Xiao, X. Liu, Y. Pan, Y. Zeng, S. Shi, Y. Peng, Y. Jiang
Journal: Journal of Thoracic Oncology (2022)
EP01.07-001 Surveillance with FDG PET/CT after Completion of Therapy for NSCLC: A Status Update on Inclusion in the SUPE_R Trial
Authors: K. Guldbrandsen, K. Skougaard, T.R. Rasmussen, B. Sørensen, L.S. Mortensen, Z. Saghir, S. Borissova, G. Persson, H. Skuladottir, S. Thisaruban, U. Bødtger, S.H. Schwaner, L.H. Land, O. Gerke, C.B. Laursen, L.B. Ahlborn, M. Pøhl, C.N. Meyer, J. Ehlers, M.S. Christophersen, C. Kristiansen, O. Hilberg, B.A. Rychwicka-Kielek, T. McCulloch, B.M. Fischer
Journal: Journal of Thoracic Oncology (2022)
EP02.03-010 Intrapulmonary and Hilar Lymph Node Dissection Performed by the Surgical Team: Impact on Pathological Stage of NSCLC
Authors: I.E.C. Farias, A.N. Silva, E.B. Lunkes, J.P.d.O. Medeci, J.B.F. Morellato, M.V.B. Baranauskas, C.A.L. Pinto, J.L. Gross
Journal: Journal of Thoracic Oncology (2022)
MA13.08 A Phase 1 Trial of Sapanisertib and Telaglenastat (CB-839) in Patients with Advanced NSCLC (NCI 10327): Results from Dose Escalation
Authors: J. Riess, P. Frankel, E. Massarelli, J. Nieva, W.-C.V. Lai, M. Koczywas, D. Shackelford, I. Lanza, J.M. Reid, W.I. Gonsalves, A.J. Remick, D.R. Gandara, R. Piekarz, P.N. Lara, E. Newman, M. Villalona-Calero, P. Paik
Journal: Journal of Thoracic Oncology (2022)
P1.16-01 Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Authors: B.C. Cho, S.-H. Lee, J.-Y. Han, E.K. Cho, J.-S. Lee, K.H. Lee, J.C. Curtin, G. Gao, J. Xie, R.W. Schnepp, J.M. Bauml, R.E. Knoblauch, M. Thayu, D.-W. Kim
Journal: Journal of Thoracic Oncology (2022)
MA05.07 Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer with MET Exon 14 Skipping
Authors: Y. Han, S. Chen, C. Xiang, L. Guo, L. Zhu, J. Shao, T. Hu, J. Wang, C. Zhu
Journal: Journal of Thoracic Oncology (2022)
P1.03-01 Do We Follow Incidental Lung Nodules Appropriately? A Retrospective Study
Authors: J.K. Pannu, G. Venious, R. Gallagher, A. Shaver, R. Cloyes, E. Josan, E. Donnelly, M. King, M. Knopp, R. Merritt, P. Kneuertz, D. D'souza, C. Ghattas, A. Revelo, N. Pastis, T. Sowers, C. Eastep, M. Ottersbach, M. Malinky, R. Reinbolt, M. Wert, J. Horowitz, D. Carbone
Journal: Journal of Thoracic Oncology (2022)
EP06.01-006 Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis
Authors: S. Ramella, A. Morabito, S. Silipigni, A. Russo, E. Capelletto, S. Rossi, A. Leonetti, M. Montrone, I. Facilissimo, G. Romano, I. Stasi, G. Ceresoli, C. Gridelli, A. Lugini, S. Pilotto, P. Tagliaferri, E. Bria, S. Canova, E. Rijavec, P. Borghetti, M. Brighenti, A.M. Carta, L. Ciuffreda, R. Giusti, M. Macerelli, F. Verderame, F. Zanelli, R. Berardi, V. Gregorc, C. Sergi, E. Vattemi, S. Manglaviti, P.L. Piovano, E. Olmetto, G. Borra, S. Gori, M. Aieta, A. Bertolini, F. Cecere, G. Pasello, D. Rocco, M. Zulian, B. Roncari, S. Novello
Journal: Journal of Thoracic Oncology (2022)
EP13.01-014 Evaluation of Malignancy and Survival in Patients Operated With a Preliminary Diagnosis of Interstitial Lung Disease
Authors: G. Kececi Ozgur, H. Yavuz, A. Ozdil, P. Korkmaz Ekren, T.&. Akcam, A.G. Ergonul, K. Turhan, A. Cakan, U. Cagirici, T.M. Ergin
Journal: Journal of Thoracic Oncology (2022)
EP08.02-047 The Impact of CGP on the Decision-making Process in ALK+ aNSCLC After Failure of 2nd/3rd-Generation ALK TKIs
Authors: E. Dudnik, A. Raphael, L. Holtzman, J. Dudnik, D. Urban, W. Kian, A. Cohen, M. Moskovitz, A. Zer, J. Bar, N. Maimon Rabinovich, S. Grynberg, C. Oedegaard, A. Agbarya, N. Peled, T. Shochat, A. Onn
Journal: Journal of Thoracic Oncology (2022)